Columnist Desiree Lama is grateful to have a kind and understanding partner, but stresses the importance of communication in ...

Both modafinil and talk therapy offer mostly equivalent, clinically meaningful benefits for fatigue in people with multiple ...

Helius is opposing decisions on how much of the costs of its PoNS device for MS can be reimbursed under U.S. public health ...

The National MS Society has awarded $4.6 million in funding for five research projects aiming to help restore lost function ...

Sanofi stopped a Phase 2 study of oditrasertib in relapsing and progressive MS after it failed to lower blood NfL levels ...

Adding Tecfidera to an immune tolerizing cell therapy could maximize therapeutic benefits for MS patients, according to a ...

Curiously, columnist Leigh Anne Nelson can't tolerate wearing socks. It's one of several foot symptoms of her MS.

A study involving identical twins suggests alterations in immune cells called CD8 T-cells may be early drivers of ...

SetPoint plans to launch a trial of its implant device, stimulating the vagus nerve to promote myelin repair, next year in ...

People with MS may have a slightly higher risk of developing cancer than the general population, per a 10-year population ...

Better adherence to an at-home therapy regimen with the PoNS device was linked to greater improvements in walking function in ...

The Foundation of the Consortium of Multiple Sclerosis Centers was gifted $100,000 by EMD Serono for its nursing scholarship ...